SteriPlas Cold Plasma to be presented at EACTS 2023

 

We look forward to Mr Thomas Schlöglhofer’s presentation at the upcoming European Association for Cardio-Thoracic Surgery (EACTS) conference in Vienna on Fri 6th Oct. Thomas will present, “Cold Atmospheric Plasma Therapy as an Effective Treatment of Left Ventricular Assist Device Driveline Infections” which will feature the advantages of our SteriPlas Cold Plasma medical device for deep LVAD infections treated at the Department of Cardiac Surgery, Medical University of Vienna.

 

https://eacts2023.process.y-congress.com/ScientificProcess/schedule/?sessionGuid=b00559d1-4eff-4ca2-a20c-8d81ee71b8cf&setLng=en


We'll be at EUMS 2023!

 

We’re looking forward to exhibiting at the annual European Mechanical Circulatory Support Summit (EUMS) from 3rd – 6th September in Paris.

 

Visit us at booth no. 5 and see the SteriPlas Cold Plasma medical device for LVAD infections on demonstration. With the strongest clinical evidence to date and our top reputation, we remain the leader of Cold Plasma medicine and continue to free hospitals and patients from the burden of LVAD infections.


SteriPlas will be presented at the ISMCS 2023

Congratulations to Mr Thomas Schlöglhofer who has been invited to speak at the International Society for Mechanical Circulatory Support Scientific Congress (ISMCS) on Wednesday 1st November 2023.

 

His presentation, “Cold Atmospheric Plasma for Driveline Infection Treatment” will focus on the benefits of the SteriPlas for LVAD infections.

 

Our medical device has proven efficacy for the treatment of deep LVAD infections with the presence of biofilm. There is growing interest to use our SteriPlas Cold Plasma for LVAD infections due to its quick ability to destroy bacteria protected within biofilm deep within driveline cavity. This is regardless of the type of bacteria or its resistance profile. As LVAD infections can be healed in as quick as 1 week, it provides stability of the independent system and a better quality of life for patients with LVADs.

 

For more information about the SteriPlas, our clinical evidence or a free trial at your hospital contact us at info@adtecplasma


Size Does Matter!

Size does matter!

Yes, we do manufacture smaller handheld Cold Plasma devices that have antibacterial efficacy but we do not sell these in the medical field. A quick 2 minute treatment time is respective of being focused on the size of the plasma area created. Small and handheld plasma jet devices feature a 1mm2 treatment area which means antibacterial efficacy is achieved in a very small area for every 2 minutes applied. If the wound is 10cm2, we will leave you to do the maths on how long it will take to treat! This is why we do not sell handheld plasma jet pens as medical devices as they are limited to small and superficial wounds.

 

The SteriPlas creates a gigantic 12cm2 treatment area which is only possible through the size of the medical device which incorporates a series of crucial components such as the generator and control unit. This means the SteriPlas can cover large wounds and finish treatment in as quick as a single two minute session. Whilst the SteriPlas can treat acute and superficial wounds, it is designed to target deep and complicated wounds with #biofilm.

Deep sternal wounds is a classic example as documented in our clinical evidence. 

 


Leading Cold Plasma medicine with the SteriPlas

 

The SteriPlas produces a repeatable, reliable, and highly efficacious Cold Plasma that has been proven in clinical trials and studies to destroy bacteria protected deep within biofilm.

 

Regardless of the resistance profile of bacteria, whether they are Gram-negative or Gram-positive, the physical mode of action of the SteriPlas Cold Plasma ensures the destruction of bacteria at the site of infection. This is particularly beneficial for difficult-to-treat or non-healing wounds such as diabetic foot ulcers, sternal wounds and LVAD infections. Where biofilm typically complicates the treatment options for these infections, the SteriPlas has been shown to fully heal patients even if they were not responding to antibiotic treatment to begin with thus saving limbs and lives.

 

All of this is achieved with the reputable safety of SteriPlas with no side effects reported.


Mr Schlöglhofer to present SteriPlas at the ISHLT

Congratulations to Thomas Schlöglhofer from the Medical University of Vienna for his continued success of using our medical device to treat infections in LVAD patients. He will be presenting at The International Society for Heart and Lung Transplantation (ISHLT) conference in April to deliver the great results he has so far achieved.

 

His presentation, “Cold Atmospheric Plasma Therapy: A Powerful Tool for Treating Driveline Infections in Left Ventricular Assist Device Patients” will be during the “Bugs, Drugs, and Thugs: Fighting Infection in VADs Any Way We Can” Session on Wednesday 19th April between 5:30 PM - 6:30 PM.

 

We hope you will be there too to see him deliver his promising results.

 

For more information on how our medical device is fighting against multi resistant bacteria and biofilm in LVAD patients.



Dr H. Rotering presenting SteriPlas DSWI efficacy at Herzmidizin 2023 conference

 

Dr Heinrich Rotering will be presenting at the Herzmedizin 2023 conference on 14th February 2023. His presentation, “Tissue saving – Plasma based treatment concept for sternal infection including one year follow-up” will show the benefits of our SteriPlas cold plasma medical device for the treatment of deep sternal wound infections.

 

The benefit our cold plasma device has for these chronic wound infections is the ability to give a deep penetration treatment allowing plasma coverage over the wide infected area. As our medical device is the only microwave-powered, argon cold plasma device with a wide 12cm2 treatment size and is contact-free, the overall sessions are quickly completed. The mean wound healing for deep sternal wound infections is 16 days with the SteriPlas.

 

Contact us at info@adtecplasma.com to learn more about the SteriPlas.


Invited to speak at the ICCAC meeting on 10th January

We are honoured to be invited to speak at The International Consortium of Circulatory Assist Clinicians (ICCAC) meeting tomorrow. Our presentation will focus on the strong benefits of the Adtec SteriPlas cold plasma for the management and healing of LVAD infections. With growing interest for an alternative therapy to failing antibiotics, the SteriPlas has been storming the medical market because of its accelerated healing, safe, effective, and harmless properties all of which will be discussed tomorrow at 3.30pm (CET).

 

Please contact us at info@adtecplasma.com for more information.  


The ISHLT discusses the Cold Plasma Project

We’re ecstatic to see our Adtec SteriPlas continue to raise awareness in the LVAD community. A great interview between the ISHLT and Mr Thomas Schlöglhofer from the Medical University of Vienna discussing the benefits of our cold atmospheric plasma medical device for the treatment of LVAD Infections and their broad study being conducted.

Thomas has been an avid user of our medical device for some time now collecting remarkable results with his LVAD patients, documenting the strong benefits of our medical device including the significant reduction of infection rates coupled with full healing, reduction of readmittance and the stabilisation of LVAD systems all with the added benefit of no side effects.

We look forward to the completion of this study and the publishing of the data which will be discussed at the ISHLT 2023 conference next year. We will also be exhibiting at this conference and excited to meet more people from the LVAD community.

 

https://youtu.be/6-L0sgXLx9o


LVAD - Heidelberg publication 2021

 

Congratulations to Dr Kremer and the Cardiology Team at The University Hospital Heidelberg for their new publication, “Follow-Up after Cold Atmospheric Argon Plasma for Wound Management of Driveline Infections - A Promising Strategy”. This publication features the use of our Adtec SteriPlas medical device for the treatment of driveline infections (DLI). The results demonstrate how the safety, reliability and painless treatment from the Adtec SteriPlas can significantly reduce the wound and infection around the DLI, with the opportunity for sustainable freedom from DLI.